Weight loss treatment information and prices

Our GPs can help you start Mounjaro or Wegovy if treatment is right for you. Repeats are requested online and delivered to your door, with GP review and support built in.

4.9★ from 2,224 reviewsOnline pharmacy prices8 London clinics with appointments
Clinician carrying out a body composition assessment

Weight loss medication prices

Injection prices cover four weekly doses. Wegovy tablet prices cover 30 tablets, taken once daily. Appointment fees are separate.

Medication supplyPrice
Wegovy 0.25mg injections£98.98
Wegovy 0.5mg injections£118.97
Wegovy 1mg injections£148.97
Wegovy 1.7mg injections£178.97
Wegovy 2.4mg injections£198.97
Mounjaro 2.5mg£168.97
Mounjaro 5mg£188.97
Mounjaro 7.5mg£248.97
Mounjaro 10mg£278.97
Mounjaro 12.5mg£288.97
Mounjaro 15mg£298.97
Wegovy 1.5 mg tablets — 30 tablets£109
Wegovy 4 mg tablets — 30 tablets£119
Wegovy 9 mg tablets — 30 tablets£149
Wegovy 25 mg tablets — 30 tablets£199

Prescribing, repeats and delivery

How treatment is prescribed and supplied

Medication is prescribed only where suitable after a GP consultation. If prescribed, it is delivered to your door, and repeat prescriptions can be requested online with GP review.

  • 1
    Start with a GP consultation
    Your GP will assess your health, weight, current medicines and suitability before discussing treatment options.
  • 2
    Prescription issued if suitable
    If treatment is right for you, your GP issues a prescription and explains how to start safely.
  • 3
    Medication delivered to your door
    If your GP prescribes treatment, your medication is usually delivered to your door within 1–2 days. Your supply contains the medication and quantity prescribed by your GP.
  • 4
    Request repeats online
    Repeat prescriptions can be requested through your DocTap account. A GP reviews each request and, if all is well, medication is delivered to your door at prices aligned with leading online pharmacies.
Doctor discussing how weight loss treatment is prescribed

Treatment options

Mounjaro and Wegovy: what’s the difference?

Mounjaro and Wegovy are prescription-only treatments for medical weight loss. Your GP will discuss the available options and help decide which is suitable for you.

Wegovy

  • Active ingredient: Semaglutide
  • How it works: Wegovy is a GLP-1 receptor agonist. It acts on appetite and fullness signals, helping reduce hunger, food cravings and calorie intake.
  • Dose: Available as a daily tablet or a weekly injection. Your GP will explain the starting dose, gradual increases and how to take your prescribed treatment.
  • Evidence: In a major clinical trial, people taking Wegovy injections lost around 15% of their body weight on average over 68 weeks. Individual results vary.
  • Your GP will consider: Your weight, medical history, current medicines, diabetes or eye history, stomach or pancreas problems, pregnancy plans and side-effect risk.

Mounjaro

  • Active ingredient: Tirzepatide
  • How it works: Mounjaro is a dual GIP and GLP-1 receptor agonist. It acts on appetite, fullness and blood-sugar pathways, helping reduce hunger, cravings and calorie intake.
  • Dose: Treatment usually starts at 2.5mg once weekly and is increased gradually if tolerated.
  • Evidence: In a major clinical trial, people taking Mounjaro lost around 15–21% of their body weight on average over 72 weeks, depending on dose. Individual results vary.
  • Your GP will consider: Your weight, medical history, current medicines, diabetes treatment, stomach or pancreas problems, pregnancy plans and side-effect risk.

Eligibility is assessed based on the criteria below and the patient’s medical history

Age reguirements

18 years or older. Treatment is not prescribed under 18. Caution is applied for patients over 75.

BMI thresholds

BMI of 30 kg/m² or more, or BMI of 27 kg/m² or more with at least one weight-related condition (for example hypertension, dyslipidaemia, obstructive sleep apnoea, prediabetes or Type 2 diabetes, PCOS, GORD, NAFLD, osteoarthritis). Ethnicity-adjusted thresholds apply for higher-risk groups.

When medication cannot be prescribed

Treatment is not prescribed in any of the following: • Pregnancy, planning pregnancy, or breastfeeding • Type 1 diabetes • Current use of insulin or sulfonylureas • Active use of another weight loss medication • Known allergy to the medication or its components • End-stage renal disease or dialysis • Active eating disorder • Severe unstable psychiatric illness • Active inflammatory bowel disease • Severe gastrointestinal disease or gastroparesis • Personal or family history of medullary thyroid cancer (Mounjaro) • MEN2 syndrome (Mounjaro) • Severe unstable retinopathy (Wegovy)

Ready to speak to a GP?

If you feel fully informed, book a consultation to discuss suitability and next steps with one of our GPs.